Peter G. Traber
2012 - Galectin Therapeutics
In 2012, Peter G. Traber earned a total compensation of $1.1M as Chief Executive Officer & President at Galectin Therapeutics, a 81% decrease compared to previous year.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Option Awards | $713,332 |
| Salary | $314,946 |
| Other | $36,021 |
| Total | $1,089,299 |
Traber received $713.3K in option awards, accounting for 65% of the total pay in 2012.
Traber also received $25K in bonus, $314.9K in salary and $36K in other compensation.
Rankings
In 2012, Peter G. Traber's compensation ranked 5,779th out of 11,487 executives tracked by ExecPay. In other words, Traber earned more than 49.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,779 out of 11,487 | 50th |
Division Manufacturing | 2,049 out of 4,253 | 52nd |
Major group Chemicals And Allied Products | 507 out of 1,203 | 58th |
Industry group Drugs | 344 out of 925 | 63rd |
Industry Pharmaceutical Preparations | 270 out of 700 | 61st |
Source: SEC filing on April 8, 2015.
Traber's colleagues
We found three more compensation records of executives who worked with Peter G. Traber at Galectin Therapeutics in 2012.